GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a significant focus in healthcare studies, largely due to its notable impact on controlling conditions such as type 2 diabetes and weight gain. Ongoing studies have demonstrated that more than glucose control, GLP-1 agoni